Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Amant

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Journal of the National Cancer Institute|December 16, 2014
Prognostic significance of POLE proofreading mutations in endometrial cancerDavid N Church, Ellen Stelloo, Remi A Nout, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
No association between FTO or HHEX and endometrial cancer riskMia M Gaudet, Hannah P Yang, Jesus Gonzalez Bosquet, et al.
The Lancet. Oncology|August 21, 2012
Treatment of breast cancer during pregnancy: an observational studySibylle Loibl, Sileny N Han, Gunter von Minckwitz, et al.
Nature|March 25, 2016
Melanoma addiction to the long non-coding RNA SAMMSONEleonora Leucci, Roberto Vendramin, Marco Spinazzi, et al.
Breast Cancer Research and Treatment|February 12, 2008
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positiveBen Van Calster, Isabelle Vanden Bempt, Maria Drijkoningen, et al.
The Journal of Pathology|December 31, 2016
Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregationFrederik De Smet, Mirian Saiz Rubio, Daphne Hompes, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 10, 2025
Pregnancy after cancer: FIGO Best practice adviceCynthia Maxwell, Sumaiya Adam, Lina Bergman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2021
Pregnancy After Breast Cancer: A Systematic Review and Meta-AnalysisMatteo Lambertini, Eva Blondeaux, Marco Bruzzone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2016
Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial CancerTarjei S Hveem, Tormund S Njølstad, Birgitte Nielsen, et al.
The Journal of Clinical Investigation|November 24, 2015
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growthMichael Dewaele, Tommaso Tabaglio, Karen Willekens, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Journal of the National Cancer Institute|December 16, 2014
Prognostic significance of POLE proofreading mutations in endometrial cancerDavid N Church, Ellen Stelloo, Remi A Nout, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
No association between FTO or HHEX and endometrial cancer riskMia M Gaudet, Hannah P Yang, Jesus Gonzalez Bosquet, et al.
The Lancet. Oncology|August 21, 2012
Treatment of breast cancer during pregnancy: an observational studySibylle Loibl, Sileny N Han, Gunter von Minckwitz, et al.
Nature|March 25, 2016
Melanoma addiction to the long non-coding RNA SAMMSONEleonora Leucci, Roberto Vendramin, Marco Spinazzi, et al.
Breast Cancer Research and Treatment|February 12, 2008
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positiveBen Van Calster, Isabelle Vanden Bempt, Maria Drijkoningen, et al.
The Journal of Pathology|December 31, 2016
Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregationFrederik De Smet, Mirian Saiz Rubio, Daphne Hompes, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 10, 2025
Pregnancy after cancer: FIGO Best practice adviceCynthia Maxwell, Sumaiya Adam, Lina Bergman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2021
Pregnancy After Breast Cancer: A Systematic Review and Meta-AnalysisMatteo Lambertini, Eva Blondeaux, Marco Bruzzone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2016
Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial CancerTarjei S Hveem, Tormund S Njølstad, Birgitte Nielsen, et al.
The Journal of Clinical Investigation|November 24, 2015
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growthMichael Dewaele, Tommaso Tabaglio, Karen Willekens, et al.
Pageof 18